Table 2 The prevalence of dyslipidemia among normal, precancerous, and cancerous lesions of the cervix in women attending the cervical cancer clinic at Uganda Cancer Institute, Mulago-Kampala, between Feb 2022 and April 2022
Variables | Â | Negative | Precancerous lesions | Cancerous lesions | Test | P-value |
|---|---|---|---|---|---|---|
N = 44 | N = 136 | N = 23 | ||||
f(%) | f(%) | f(%) | ||||
HDL-c | HDL-c DYSLIIDEMIA | 6 (13.6%) | 39 (28.7%) | 11 (47.8%) | Chi-square | 0.011* |
NORMAL HDL-c | 38 (86.4%) | 97 (71.3%) | 12 (52.2%) | Â | Â | |
TG-c | NORMAL TRIG | 40 (90.9%) | 104 (76.5%) | 10 (43.5%) | Fisher’s exact |  < 0.001* |
TRIG DYSLIPIDEMIA | 4 ( 9.1%) | 32 (23.5%) | 13 (56.5%) | Â | Â | |
LDL-c | NORMAL LDL-c | 34 (77.3%) | 91 (66.9%) | 9 (39.1%) | Chi-square | 0.007* |
LDL-c DYSLIPIDEMIA | 10 (22.7%) | 45 (33.1%) | 14 (60.9%) | Â | Â | |
TC | NORMAL TCHOL | 41 (93.2%) | 98 (72.1%) | 13 (56.5%) | Fisher’s exact |  < 0.001* |
TCHOL DYSLIPIDEMIA | 3 ( 6.8%) | 38 (27.9%) | 10 (43.5%) | Â | Â |